As proposed in monoamine hypothesis, low level of serotonin in MDD patients is the target of antidepressant drugs, like SSRIs, which exert antidepressant effect through reducing SERT expression in serotonergic raphe nuclei via binding to SERT [27]. The gene discussed is SLC6A4; the disease is major depressive disorder.